Teva Is On The Prowl And Its Investors Are Taking Notice | Mint
Teva: Warren Buffett Messed Things Up For Short-Sellers - Bloomberg
Teva's CEO on Why the Drugmaker Is Confident Despite Covid-19 | Barron's
The Difficulties of Cloning a CEO - Bloomberg
Allergan becomes largest shareholder in Teva - Globes
Teva Gets Generic Drugmakers' Backing in Bid to Redo Label Case
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Kare Schultz, president and chief executive officer of Teva... News Photo - Getty Images
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva: Reportedly Planning Thousands of Layoffs in the U.S. | Fortune
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
How Uggs, Hoka, and Tevas Helped Build Deckers' $2.5 Billion Ugly-Shoe Empire - Bloomberg
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
Teva CEO Vigodman steps down as drugmaker seeks direction | The Times of Israel
Teva Pharmaceuticals (TEVA) Stock Gets Upgraded at HSBC - TheStreet
Teva's CEO Was $2.8 Billion Down on His Second Day on the Job - Bloomberg
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva CEO Says Drugmaker Will Fight US Price-Fixing Charges (2)
Drug giants line up for Irish legal battle over patents - Independent.ie
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York state - KTVZ
Teva Pharmaceuticals CEO steps down as shares continue descent - BNN Bloomberg
Israel's Teva offering free drugs to settle U.S. opiods case - Business - Haaretz.com
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg - Benzinga
Teva's Budding Blockbusters Lend Respite From Legal Concerns
